APO Research

APO RESEARCH · REPORT

Chicken Medicine and Vaccines

Selected research

Market Outlook & Growth Opportunities

Global Chicken Medicine and Vaccines Market Outlook and Growth Opportunities 2026

Market perspective

The global Chicken Medicine and Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chicken Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chicken Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chicken Medicine and Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chicken Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chicken Medicine and Vaccines market include CAVAC, CEVA, DHN, Elanco (Lohmann), FATRO, Merial, QYH Biotech, Ringpu Biology and Vaksindo, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chicken Medicine and Vaccines market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chicken Medicine and Vaccines and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chicken Medicine and Vaccines revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chicken Medicine and Vaccines market.

Chicken Medicine and Vaccines Segment by Company

CAVAC

CEVA

DHN

Elanco (Lohmann)

FATRO

Merial

QYH Biotech

Ringpu Biology

Vaksindo

Yebio

Zoetis

ChengDu Tecbond

Merck Animal Health

Harbin Veterinary Research Institute

Chicken Medicine and Vaccines Segment by Type

Medicine

Vaccines

Chicken Medicine and Vaccines Segment by Application

Farm

Government

Chicken Medicine and Vaccines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Chicken Medicine and Vaccines status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chicken Medicine and Vaccines key companies, revenue, market share, and recent developments.

3. To split the Chicken Medicine and Vaccines breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chicken Medicine and Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chicken Medicine and Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Chicken Medicine and Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chicken Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chicken Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chicken Medicine and Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chicken Medicine and Vaccines industry.

Chapter 3: Detailed analysis of Chicken Medicine and Vaccines company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chicken Medicine and Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chicken Medicine and Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chicken Medicine and Vaccines Industry Trends Table 2. Chicken Medicine and Vaccines Industry Drivers Table 3. Chicken Medicine and Vaccines Industry Opportunities and Challenges Table 4. Chicken Medicine and Vaccines Industry Restraints Table 5. Global Chicken Medicine and Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chicken Medicine and Vaccines Revenue Share by Company (2021-2026) Table 7. Global Chicken Medicine and Vaccines Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chicken Medicine and Vaccines Key Company Manufacturing Base & Headquarters Table 9. Global Chicken Medicine and Vaccines Company, Product Type & Application Table 10. Global Chicken Medicine and Vaccines Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chicken Medicine and Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Medicine Table 15. Significant Companies of Vaccines Table 16. Global Chicken Medicine and Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Chicken Medicine and Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Chicken Medicine and Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Chicken Medicine and Vaccines Sales Value Share by Type (2021-2026) Table 20. Global Chicken Medicine and Vaccines Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Farm Table 22. Significant Companies of Government Table 23. Global Chicken Medicine and Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Chicken Medicine and Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Chicken Medicine and Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Chicken Medicine and Vaccines Sales Value Share by Application (2021-2026) Table 27. Global Chicken Medicine and Vaccines Sales Value Share by Application (2027-2032) Table 28. Global Chicken Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Chicken Medicine and Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Chicken Medicine and Vaccines Sales Value Share by Region (2021-2026) Table 31. Global Chicken Medicine and Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Chicken Medicine and Vaccines Sales Value Share by Region (2027-2032) Table 33. Global Chicken Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Chicken Medicine and Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Chicken Medicine and Vaccines Sales Value Market Share by Country (2021-2026) Table 36. Global Chicken Medicine and Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Chicken Medicine and Vaccines Sales Value Market Share by Country (2027-2032) Table 38. CAVAC Company Information Table 39. CAVAC Business Overview Table 40. CAVAC Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. CAVAC Chicken Medicine and Vaccines Product Portfolio Table 42. CAVAC Recent Development Table 43. CEVA Company Information Table 44. CEVA Business Overview Table 45. CEVA Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. CEVA Chicken Medicine and Vaccines Product Portfolio Table 47. CEVA Recent Development Table 48. DHN Company Information Table 49. DHN Business Overview Table 50. DHN Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. DHN Chicken Medicine and Vaccines Product Portfolio Table 52. DHN Recent Development Table 53. Elanco (Lohmann) Company Information Table 54. Elanco (Lohmann) Business Overview Table 55. Elanco (Lohmann) Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Elanco (Lohmann) Chicken Medicine and Vaccines Product Portfolio Table 57. Elanco (Lohmann) Recent Development Table 58. FATRO Company Information Table 59. FATRO Business Overview Table 60. FATRO Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. FATRO Chicken Medicine and Vaccines Product Portfolio Table 62. FATRO Recent Development Table 63. Merial Company Information Table 64. Merial Business Overview Table 65. Merial Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Merial Chicken Medicine and Vaccines Product Portfolio Table 67. Merial Recent Development Table 68. QYH Biotech Company Information Table 69. QYH Biotech Business Overview Table 70. QYH Biotech Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. QYH Biotech Chicken Medicine and Vaccines Product Portfolio Table 72. QYH Biotech Recent Development Table 73. Ringpu Biology Company Information Table 74. Ringpu Biology Business Overview Table 75. Ringpu Biology Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ringpu Biology Chicken Medicine and Vaccines Product Portfolio Table 77. Ringpu Biology Recent Development Table 78. Vaksindo Company Information Table 79. Vaksindo Business Overview Table 80. Vaksindo Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Vaksindo Chicken Medicine and Vaccines Product Portfolio Table 82. Vaksindo Recent Development Table 83. Yebio Company Information Table 84. Yebio Business Overview Table 85. Yebio Chicken Medicine and Vaccines Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Yebio Chicken Medicine and Vaccines Product Portfolio Table 87. Yebio Recent Development Table 88. Zoetis Company Information Table 89. Zoetis Business Overview Table 90. Zoetis Chicken Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Zoetis Chicken Medicine and Vaccines Product Portfolio Table 92. Zoetis Recent Development Table 93. ChengDu Tecbond Company Information Table 94. ChengDu Tecbond Business Overview Table 95. ChengDu Tecbond Chicken Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. ChengDu Tecbond Chicken Medicine and Vaccines Product Portfolio Table 97. ChengDu Tecbond Recent Development Table 98. Merck Animal Health Company Information Table 99. Merck Animal Health Business Overview Table 100. Merck Animal Health Chicken Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Merck Animal Health Chicken Medicine and Vaccines Product Portfolio Table 102. Merck Animal Health Recent Development Table 103. Harbin Veterinary Research Institute Company Information Table 104. Harbin Veterinary Research Institute Business Overview Table 105. Harbin Veterinary Research Institute Chicken Medicine and Vaccines Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Harbin Veterinary Research Institute Chicken Medicine and Vaccines Product Portfolio Table 107. Harbin Veterinary Research Institute Recent Development Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Chicken Medicine and Vaccines Product Image Figure 2. Global Chicken Medicine and Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chicken Medicine and Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Chicken Medicine and Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Medicine Image Figure 8. Vaccines Image Figure 9. Global Chicken Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Chicken Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Chicken Medicine and Vaccines Sales Value Share by Type (2021-2032) Figure 12. Farm Image Figure 13. Government Image Figure 14. Global Chicken Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Chicken Medicine and Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Chicken Medicine and Vaccines Sales Value Share by Application (2021-2032) Figure 17. Global Chicken Medicine and Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Chicken Medicine and Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Chicken Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 20. North America Chicken Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Chicken Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Chicken Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Chicken Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Chicken Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Chicken Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 26. South America Chicken Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Chicken Medicine and Vaccines Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Chicken Medicine and Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Medicine
  • Vaccines
Applications
  • Farm
  • Government
Companies covered
  • CAVAC
  • CEVA
  • DHN
  • Elanco (Lohmann)
  • FATRO
  • Merial
  • QYH Biotech
  • Ringpu Biology
  • Vaksindo
  • Yebio
  • Zoetis
  • ChengDu Tecbond
  • Merck Animal Health
  • Harbin Veterinary Research Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chicken Medicine and Vaccines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chicken Medicine and Vaccines Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chicken Medicine and Vaccines Market Dynamics
  1. 2.1 Chicken Medicine and Vaccines Industry Trends
  2. 2.2 Chicken Medicine and Vaccines Industry Drivers
  3. 2.3 Chicken Medicine and Vaccines Industry Opportunities and Challenges
  4. 2.4 Chicken Medicine and Vaccines Industry Restraints
3 Chicken Medicine and Vaccines Market by Company
  1. 3.1 Global Chicken Medicine and Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Chicken Medicine and Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Chicken Medicine and Vaccines Company Ranking (2024-2026)
  4. 3.4 Global Chicken Medicine and Vaccines Company Manufacturing Base and Headquarters
  5. 3.5 Global Chicken Medicine and Vaccines Company Product Type and Application
  6. 3.6 Global Chicken Medicine and Vaccines Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chicken Medicine and Vaccines Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chicken Medicine and Vaccines Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chicken Medicine and Vaccines Market by Type
  1. 4.1 Chicken Medicine and Vaccines Type Introduction
  2. 4.1.1 Medicine
  3. 4.1.2 Vaccines
  4. 4.2 Global Chicken Medicine and Vaccines Sales Value by Type
  5. 4.2.1 Global Chicken Medicine and Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chicken Medicine and Vaccines Sales Value by Type (2021-2032)
  7. 4.2.3 Global Chicken Medicine and Vaccines Sales Value Share by Type (2021-2032)
5 Chicken Medicine and Vaccines Market by Application
  1. 5.1 Chicken Medicine and Vaccines Application Introduction
  2. 5.1.1 Farm
  3. 5.1.2 Government
  4. 5.2 Global Chicken Medicine and Vaccines Sales Value by Application
  5. 5.2.1 Global Chicken Medicine and Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chicken Medicine and Vaccines Sales Value by Application (2021-2032)
  7. 5.2.3 Global Chicken Medicine and Vaccines Sales Value Share by Application (2021-2032)
6 Chicken Medicine and Vaccines Regional Value Analysis
  1. 6.1 Global Chicken Medicine and Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chicken Medicine and Vaccines Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chicken Medicine and Vaccines Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chicken Medicine and Vaccines Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chicken Medicine and Vaccines Sales Value (2021-2032)
  7. 6.3.2 North America Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chicken Medicine and Vaccines Sales Value (2021-2032)
  10. 6.4.2 Europe Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chicken Medicine and Vaccines Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chicken Medicine and Vaccines Sales Value (2021-2032)
  16. 6.6.2 South America Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chicken Medicine and Vaccines Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chicken Medicine and Vaccines Sales Value Share by Country, 2025 VS 2032
7 Chicken Medicine and Vaccines Country-level Value Analysis
  1. 7.1 Global Chicken Medicine and Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chicken Medicine and Vaccines Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chicken Medicine and Vaccines Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chicken Medicine and Vaccines Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chicken Medicine and Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chicken Medicine and Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chicken Medicine and Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CAVAC
  2. 8.1.1 CAVAC Company Information
  3. 8.1.2 CAVAC Business Overview
  4. 8.1.3 CAVAC Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CAVAC Chicken Medicine and Vaccines Product Portfolio
  6. 8.1.5 CAVAC Recent Developments
  7. 8.2 CEVA
  8. 8.2.1 CEVA Company Information
  9. 8.2.2 CEVA Business Overview
  10. 8.2.3 CEVA Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  11. 8.2.4 CEVA Chicken Medicine and Vaccines Product Portfolio
  12. 8.2.5 CEVA Recent Developments
  13. 8.3 DHN
  14. 8.3.1 DHN Company Information
  15. 8.3.2 DHN Business Overview
  16. 8.3.3 DHN Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  17. 8.3.4 DHN Chicken Medicine and Vaccines Product Portfolio
  18. 8.3.5 DHN Recent Developments
  19. 8.4 Elanco (Lohmann)
  20. 8.4.1 Elanco (Lohmann) Company Information
  21. 8.4.2 Elanco (Lohmann) Business Overview
  22. 8.4.3 Elanco (Lohmann) Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Elanco (Lohmann) Chicken Medicine and Vaccines Product Portfolio
  24. 8.4.5 Elanco (Lohmann) Recent Developments
  25. 8.5 FATRO
  26. 8.5.1 FATRO Company Information
  27. 8.5.2 FATRO Business Overview
  28. 8.5.3 FATRO Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  29. 8.5.4 FATRO Chicken Medicine and Vaccines Product Portfolio
  30. 8.5.5 FATRO Recent Developments
  31. 8.6 Merial
  32. 8.6.1 Merial Company Information
  33. 8.6.2 Merial Business Overview
  34. 8.6.3 Merial Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Merial Chicken Medicine and Vaccines Product Portfolio
  36. 8.6.5 Merial Recent Developments
  37. 8.7 QYH Biotech
  38. 8.7.1 QYH Biotech Company Information
  39. 8.7.2 QYH Biotech Business Overview
  40. 8.7.3 QYH Biotech Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  41. 8.7.4 QYH Biotech Chicken Medicine and Vaccines Product Portfolio
  42. 8.7.5 QYH Biotech Recent Developments
  43. 8.8 Ringpu Biology
  44. 8.8.1 Ringpu Biology Company Information
  45. 8.8.2 Ringpu Biology Business Overview
  46. 8.8.3 Ringpu Biology Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ringpu Biology Chicken Medicine and Vaccines Product Portfolio
  48. 8.8.5 Ringpu Biology Recent Developments
  49. 8.9 Vaksindo
  50. 8.9.1 Vaksindo Company Information
  51. 8.9.2 Vaksindo Business Overview
  52. 8.9.3 Vaksindo Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Vaksindo Chicken Medicine and Vaccines Product Portfolio
  54. 8.9.5 Vaksindo Recent Developments
  55. 8.10 Yebio
  56. 8.10.1 Yebio Company Information
  57. 8.10.2 Yebio Business Overview
  58. 8.10.3 Yebio Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yebio Chicken Medicine and Vaccines Product Portfolio
  60. 8.10.5 Yebio Recent Developments
  61. 8.11 Zoetis
  62. 8.11.1 Zoetis Company Information
  63. 8.11.2 Zoetis Business Overview
  64. 8.11.3 Zoetis Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Zoetis Chicken Medicine and Vaccines Product Portfolio
  66. 8.11.5 Zoetis Recent Developments
  67. 8.12 ChengDu Tecbond
  68. 8.12.1 ChengDu Tecbond Company Information
  69. 8.12.2 ChengDu Tecbond Business Overview
  70. 8.12.3 ChengDu Tecbond Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  71. 8.12.4 ChengDu Tecbond Chicken Medicine and Vaccines Product Portfolio
  72. 8.12.5 ChengDu Tecbond Recent Developments
  73. 8.13 Merck Animal Health
  74. 8.13.1 Merck Animal Health Company Information
  75. 8.13.2 Merck Animal Health Business Overview
  76. 8.13.3 Merck Animal Health Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Merck Animal Health Chicken Medicine and Vaccines Product Portfolio
  78. 8.13.5 Merck Animal Health Recent Developments
  79. 8.14 Harbin Veterinary Research Institute
  80. 8.14.1 Harbin Veterinary Research Institute Company Information
  81. 8.14.2 Harbin Veterinary Research Institute Business Overview
  82. 8.14.3 Harbin Veterinary Research Institute Chicken Medicine and Vaccines Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Harbin Veterinary Research Institute Chicken Medicine and Vaccines Product Portfolio
  84. 8.14.5 Harbin Veterinary Research Institute Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research